Strategies of endoleak management following endoluminal treatment of abdominal aortic aneurysms in 95 patients: how, when and why.
OBJECTIVE
This study reviews, on the basis of our experience, the indications and options for treating endoleaks (EL) after endovascular repair of abdominal aortic aneurysms (AAA) by endografting.


METHODS
Ninety-five patients (M/F =92/3; mean age at time of operation 70.7+/-7.8 years) who underwent endovascular repair of infrarenal AAA between April 1997 and October 2004 were considered. All images of 420 pre-and postoperative computed tomography (CT) studies were reviewed.


RESULTS
A total of 37 EL occurred in 33/95 patients (34.7%), four of whom had two EL of different types. Eighteen EL were treated, 16 by endoluminal treatment. Six EL were type I: 2 were treated by percutaneous transluminal angioplasty (PTA) and 4 by cuff deployment (2 proximal cuffs and 2 distal cuffs). Eight EL were type II: 2 were treated by PTA, 2 by cuff deployment, 1 by transcatheter coil embolisation of the inferior mesenteric artery, two by thrombin injection in the aneurysm sac and one underwent surgical conversion during an attempt to treat a concomitant type I EL. Finally, 2 EL were type III: 1 was treated by PTA and 1 by cuff deployment. Endovascular treatment was successful in 12/16 cases (75%), whereas 3/16 cases (18.8%) were converted to open surgery, and 1 patient died of AAA rupture the day after endovascular repair.


CONCLUSIONS
EL is the most common complication after endovascular repair of AAA. In type I and type III EL, treatment is mandatory, whereas in type II (and type V) EL, treatment is indicated in the presence of AAA enlargement. Type IV EL generally disappear spontaneously. Endovascular repair is feasible and can be performed with different techniques according to EL aetiology, but it is not always decisive, and in some cases surgical conversion is required.
Barbiero
G
G
Dipartimento di Scienze Medico-Diagnostiche e Terapie Speciali, Sezione di Radiologia, Università di Padova, Padova, Italy. giuliobarbiero@katamail.com
Baratto
A
A
Ferro
F
F
Dall'Acqua
J
J
Fittà
C
C
Miotto
D
D
D000368:Aged; D000369:Aged, 80 and over; D000800:Angioplasty, Balloon; D017544:Aortic Aneurysm, Abdominal / Q000000981:diagnostic imaging / Q000601:surgery*; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects*; D004621:Embolization, Therapeutic; D005260:Female; D006801:Humans; D008297:Male; D011183:Postoperative Complications / Q000145:classification / Q000000981:diagnostic imaging / Q000601:surgery / Q000628:therapy*; D011475:Prosthesis Failure; D012086:Reoperation; D013917:Thrombin / Q000008:administration & dosage; D014057:Tomography, X-Ray Computed
D013917:Thrombin
Tech Vasc Interv Radiol. 2005 Mar;8(1):41-9
16098936
J Vasc Surg. 1998 Jan;27(1):69-78; discussion 78-80
9474084
AJR Am J Roentgenol. 2000 Dec;175(6):1649-51
11090397
Radiology. 2003 May;227(2):426-33
12676973
J Endovasc Surg. 1998 Nov;5(4):305-9
9867318
J Vasc Surg. 2006 May;43(5):896-902
16678679
Radiol Med. 2000 Jan-Feb;99(1-2):22-5
10803181
J Endovasc Surg. 1999 Nov;6(4):308-15
10893130
J Vasc Surg. 2003 Jun;37(6):1155-61
12764258
Radiol Med. 2006 Oct;111(7):931-48
17021688
J Vasc Surg. 2001 Jul;34(1):98-105
11436081
J Endovasc Surg. 1999 May;6(2):136-46
10473331
J Endovasc Surg. 1997 May;4(2):152-68
9185003
J Vasc Surg. 2003 Apr;37(4):842-6
12663987
Eur J Vasc Endovasc Surg. 2000 Apr;19(4):421-5
10801377
Am J Surg. 1999 Sep;178(3):225-31
10527444
Radiology. 2000 May;215(2):409-13
10796917
J Vasc Surg. 2000 Jan;31(1 Pt 1):134-46
10642716
Acta Biomed. 2003;74 Suppl 2:45-50
15055034
J Endovasc Surg. 1999 Nov;6(4):305-7
10893129
J Vasc Interv Radiol. 1996 Nov-Dec;7(6):813-7
8951747
J Cardiovasc Surg (Torino). 2003 Aug;44(4):553-7
14627229
J Endovasc Surg. 1996 Feb;3(1):124-5
8991758
J Vasc Surg. 2002 Mar;35(3):461-73
11877693
Radiol Med. 2007 Apr;112(3):409-19
17440694
J Endovasc Ther. 2001 Oct;8(5):503-10
11718410